SCHEMBL13691920

SCHEMBL13691920

O=C(Cl)C(Br)CCCN1C(=O)c2ccccc2C1=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 5/20 0.48
HDAC7 Q8WUI4 5/20 0.48
HDAC8 Q9BY41 3/20 0.48
HDAC3 O15379 2/20 0.48
HDAC4 P56524 2/20 0.48
HDAC2 Q92769 2/20 0.48
HDAC10 Q969S8 2/20 0.48
HDAC11 Q96DB2 2/20 0.48
HDAC6 Q9UBN7 2/20 0.48
HDAC9 Q9UKV0 2/20 0.48
HDAC5 Q9UQL6 2/20 0.48
CA12 O43570 1/20 0.47
CA9 Q16790 1/20 0.47
MMP2 P08253 1/20 0.47
MMP9 P14780 1/20 0.47
TDP1 Q9NUW8 2/20 0.46
KMT2A Q03164 1/20 0.46
ALDH1A1 P00352 1/20 0.46
ACHE P22303 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7898753 0.86 HDAC7 (0.52) HDAC1HDAC7HDAC8HDAC3HDAC4
SCHEMBL3359985 0.86 HDAC7 (0.52) HDAC1HDAC7HDAC8HDAC3HDAC4
SCHEMBL6954199 0.86 HDAC7 (0.52) HDAC1HDAC7HDAC8HDAC3HDAC4
SCHEMBL7438587 0.85 NPC1 (0.50) HDAC1HDAC7HDAC8HDAC3HDAC4
SCHEMBL6966437 0.82 HDAC1 (0.58) HDAC1HDAC7HDAC8HDAC3HDAC4
SCHEMBL6510657 0.82 HDAC1 (0.58) HDAC1HDAC7HDAC8HDAC3HDAC4
SCHEMBL10667117 0.81 HDAC1 (0.56) HDAC1HDAC7HDAC8HDAC3HDAC4
SCHEMBL10666776 0.81 HDAC1 (0.56) HDAC1HDAC7HDAC8HDAC3HDAC4
SCHEMBL13686537 0.81 HDAC1 (0.53) HDAC1HDAC7HDAC8HDAC3HDAC4
SCHEMBL442293 0.78 MMP2 (0.44) HDAC1HDAC7HDAC8HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009115321-A1 MIDAZOPYRIMIDINE, IMIDAZOPYRAZINE AND IMIDAZOPYRIDAZINE DERIVATIVES AS MELANOCORTIN-4 RECEPTOR MODULATORS SANTHERA PHARMACEUTICALS (SCHWEIZ) AG (CH) 2009-09-24 WO disclosed
EP-2103614-A1 Substituted imidazopyrimidine, imidazopyrazine and imidazopyridazine derivatives as melanocortin-4 receptor modulators Santhera Pharmaceuticals (Schweiz) AG (CH) 2009-09-23 EP disclosed